| Year |
Citation |
Score |
| 2013 |
Trimmer C, Sotgia F, Lisanti MP, Capozza F. Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation. American Journal of Translational Research. 5: 80-91. PMID 23390568 |
0.378 |
|
| 2013 |
Trimmer C, Bonuccelli G, Katiyar S, Sotgia F, Pestell RG, Lisanti MP, Capozza F. Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation. The American Journal of Pathology. 182: 992-1004. PMID 23267770 DOI: 10.1016/J.Ajpath.2012.11.008 |
0.494 |
|
| 2013 |
Trimmer C, Capozza F. Abstract 1631: Cav1 is a key mediator of tumor-stromal interactions in melanoma. Cancer Research. 73: 1631-1631. DOI: 10.1158/1538-7445.Am2013-1631 |
0.503 |
|
| 2012 |
Bonuccelli G, Castello-Cros R, Capozza F, Martinez-Outschoorn UE, Lin Z, Tsirigos A, Xuanmao J, Whitaker-Menezes D, Howell A, Lisanti MP, Sotgia F. The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis. Cell Cycle (Georgetown, Tex.). 11: 3972-82. PMID 23047602 DOI: 10.4161/Cc.22227 |
0.479 |
|
| 2012 |
Capozza F, Trimmer C, Castello-Cros R, Katiyar S, Whitaker-Menezes D, Follenzi A, Crosariol M, Llaverias G, Sotgia F, Pestell RG, Lisanti MP. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration. Cancer Research. 72: 2262-74. PMID 22396494 DOI: 10.1158/0008-5472.Can-11-2593 |
0.522 |
|
| 2011 |
Castello-Cros R, Bonuccelli G, Molchansky A, Capozza F, Witkiewicz AK, Birbe RC, Howell A, Pestell RG, Whitaker-Menezes D, Sotgia F, Lisanti MP. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis. Cell Cycle (Georgetown, Tex.). 10: 2021-34. PMID 21646868 DOI: 10.4161/Cc.10.12.16002 |
0.498 |
|
| 2011 |
Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/J.Ajpath.2010.11.005 |
0.422 |
|
| 2011 |
Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez-Outschoorn UE, Pavlides S, Howell A, Iozzo RV, Pestell RG, Scherer PE, Capozza F, Lisanti MP. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biology & Therapy. 11: 383-94. PMID 21150282 DOI: 10.4161/Cbt.11.4.14101 |
0.486 |
|
| 2011 |
Trimmer C, Katiyar S, Pestell RG, Lisanti MP, Capozza F. Abstract 1083: Caveolin-1 in cutaneous squamous cell carcinoma development Cancer Research. 71: 1083-1083. DOI: 10.1158/1538-7445.Am2011-1083 |
0.496 |
|
| 2010 |
Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, Wang C, Pavlides S, Martinez-Cantarin MP, Capozza F, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Caro J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment. Cell Cycle (Georgetown, Tex.). 9: 3515-33. PMID 20855962 DOI: 10.4161/Cc.9.17.12928 |
0.452 |
|
| 2010 |
Trimmer C, Whitaker-Menezes D, Bonuccelli G, Milliman JN, Daumer KM, Aplin AE, Pestell RG, Sotgia F, Lisanti MP, Capozza F. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway. Cancer Research. 70: 7489-99. PMID 20709760 DOI: 10.1158/0008-5472.Can-10-0900 |
0.532 |
|
| 2010 |
Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, et al. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle (Georgetown, Tex.). 9: 1960-71. PMID 20495363 DOI: 10.4161/Cc.9.10.11601 |
0.496 |
|
| 2009 |
Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. The American Journal of Pathology. 174: 1650-62. PMID 19395651 DOI: 10.2353/Ajpath.2009.080648 |
0.473 |
|
| 2009 |
Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. The American Journal of Pathology. 174: 613-29. PMID 19164602 DOI: 10.2353/Ajpath.2009.080653 |
0.541 |
|
| 2008 |
Chen J, Capozza F, Wu A, Deangelis T, Sun H, Lisanti M, Baserga R. Regulation of insulin receptor substrate-1 expression levels by caveolin-1. Journal of Cellular Physiology. 217: 281-9. PMID 18506777 DOI: 10.1002/Jcp.21498 |
0.372 |
|
| 2008 |
Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behavioural Brain Research. 188: 255-62. PMID 18083242 DOI: 10.1016/J.Bbr.2007.11.002 |
0.333 |
|
| 2007 |
Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, Pestell RG, Loda M, Freeman MR, Lisanti MP. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biology & Therapy. 6: 1263-8. PMID 17786030 DOI: 10.4161/Cbt.6.8.4447 |
0.4 |
|
| 2007 |
Bonuccelli G, Sotgia F, Capozza F, Gazzerro E, Minetti C, Lisanti MP. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. Cell Cycle (Georgetown, Tex.). 6: 1242-8. PMID 17495527 DOI: 10.4161/Cc.6.10.4182 |
0.36 |
|
| 2007 |
Schubert W, Sotgia F, Cohen AW, Capozza F, Bonuccelli G, Bruno C, Minetti C, Bonilla E, Dimauro S, Lisanti MP. Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. The American Journal of Pathology. 170: 316-33. PMID 17200204 DOI: 10.2353/Ajpath.2007.060687 |
0.366 |
|
| 2006 |
Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. The American Journal of Pathology. 169: 1784-801. PMID 17071600 DOI: 10.2353/Ajpath.2006.060590 |
0.509 |
|
| 2005 |
Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. American Journal of Physiology. Cell Physiology. 288: C1317-31. PMID 15689413 DOI: 10.1152/Ajpcell.00489.2004 |
0.304 |
|
| 2005 |
Capozza F, Cohen AW, Cheung MW, Sotgia F, Schubert W, Battista M, Lee H, Frank PG, Lisanti MP. Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells. American Journal of Physiology. Cell Physiology. 288: C677-91. PMID 15548572 DOI: 10.1152/Ajpcell.00232.2004 |
0.373 |
|
| 2003 |
Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. The American Journal of Pathology. 163: 2619-34. PMID 14633633 DOI: 10.1016/S0002-9440(10)63616-4 |
0.328 |
|
| 2003 |
Sotgia F, Woodman SE, Bonuccelli G, Capozza F, Minetti C, Scherer PE, Lisanti MP. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease. American Journal of Physiology. Cell Physiology. 285: C1150-60. PMID 12839838 DOI: 10.1152/Ajpcell.00166.2003 |
0.309 |
|
| 2003 |
Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, Sotgia F, Lisanti MP. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. The American Journal of Pathology. 162: 2029-39. PMID 12759258 DOI: 10.1016/S0002-9440(10)64335-0 |
0.505 |
|
| 2002 |
Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, Capozza F, Schubert AL, Minetti C, Buckley JT, Lisanti MP. Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Molecular and Cellular Biology. 22: 3905-26. PMID 11997523 DOI: 10.1128/Mcb.22.11.3905-3926.2002 |
0.405 |
|
| 2001 |
Galbiati F, Volonte' D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP. Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism Molecular Biology of the Cell. 12: 2229-2244. PMID 11514613 DOI: 10.1091/Mbc.12.8.2229 |
0.386 |
|
| Show low-probability matches. |